Laure Gossec to Clinical Trials as Topic
This is a "connection" page, showing publications Laure Gossec has written about Clinical Trials as Topic.
Connection Strength
0.276
-
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1014-1020.
Score: 0.048
-
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. J Rheumatol. 2019 08; 46(8):1021-1027.
Score: 0.048
-
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1028-1035.
Score: 0.048
-
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials. J Rheumatol. 2019 08; 46(8):990-995.
Score: 0.047
-
How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review. Ann Rheum Dis. 2018 05; 77(5):782-783.
Score: 0.043
-
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. J Rheumatol. 2017 Oct; 44(10):1522-1528.
Score: 0.042